Thus, IDO1 was overexpressed in HCC tissues and could be further upregulated by HSV-1 treatment, which acted as a negative feedback mechanism of the immune system to limit HSV-1 replication in the tumor cells. The gene discussed is IDO1; the disease is hepatocellular carcinoma.